This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2002-2013.
Company Filing History:
Years Active: 2002-2013
Title: Gerald Lewis Kaplan: Innovator in Pharmaceutical Chemistry
Introduction
Gerald Lewis Kaplan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing novel compounds that have potential therapeutic applications.
Latest Patents
Kaplan's latest patents include innovative compounds such as 4-dimethylaminobutyric acid derivatives. This invention relates to novel derivatives that inhibit carnitine palmitoyl transferase (CPT) activity, particularly CPT2 activity. These compounds can be utilized as medicaments in treating diseases modulated by CPT2 inhibitors. Another significant patent involves 4-pyridinyl-n-acyl-l-phenylalanines, which are useful for treating diseases related to the binding of VCAM-1 to cells expressing VLA-4.
Career Highlights
Gerald Kaplan is currently associated with Hoffmann-La Roche Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that address critical health issues.
Collaborations
Kaplan has collaborated with notable colleagues such as Jefferson Wright Tilley and Achyutharao Sidduri, contributing to a dynamic research environment that fosters innovation.
Conclusion
Gerald Lewis Kaplan's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.